LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Sirolimus‐coated balloon versus everolimus‐eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial

Photo from wikipedia

Percutaneous coronary intervention (PCI) with drug‐eluting stent (DES) implantation is a widely adopted strategy for the treatment of de novo coronary artery disease. DES implantation conveys an inherent risk for… Click to show full abstract

Percutaneous coronary intervention (PCI) with drug‐eluting stent (DES) implantation is a widely adopted strategy for the treatment of de novo coronary artery disease. DES implantation conveys an inherent risk for short‐ and long‐term complications, including in‐stent restenosis and stent thrombosis. Drug‐coated balloons are emerging as an alternative approach to fulfill the “leaving nothing behind” principle and avoid long‐term DES‐related complications.

Keywords: eluting stent; coronary artery; artery disease; novo coronary

Journal Title: Catheterization and Cardiovascular Interventions
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.